Prelude Therapeutics, Inc. (PRLD)
3.46
+0.01
(+0.29%)
USD |
NASDAQ |
Apr 02, 16:00
3.47
+0.01
(+0.29%)
After-Hours: 20:00
Prelude Therapeutics Total Assets (Quarterly) : 141.32M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Incyte Corp. | 6.971B |
| Immunome, Inc. | 683.19M |
| Sana Biotechnology, Inc. | 426.72M |
| Definitive Healthcare Corp. | 735.49M |
| Moderna, Inc. | 12.34B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 72.68M |
| Shareholders Equity (Quarterly) | 68.64M |
| Debt to Equity Ratio | 0.2592 |
| Current Ratio | 1.994 |
| Net Debt Paydown Yield | 0.04% |